Author:
Buss Joan L.,Hasinoff Brian B.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Toxicology,Pharmacology,Immunology
Reference35 articles.
1. J. L. Speyer, M. D. Green, E. Kramer, M. Rey, J. Sanger, C. Ward, N. Dubin, V. Ferrans, P. Stecy, A. Zeleniuch-Jacquotte, J. Wernz, F. Feit, W. Slater, R. Blum and F. Muggia,Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. New Engl. J. Med.319, 745–752 (1988).
2. J. L. Speyer, M. D. Green, A. Zeleniuch-Jacquotte, J. C. Wernz, M. Rey, J. Sanger, E. Kramer, V. Ferrans, H. Hochster, M. Meyers, R. H. Blum, F. Feit, M.Attubato, W. Burrows and F. M. Muggia,ICRF-187 permits longer treatment with doxorubicin in women with breast cancer. J. Clin. Oncol.10, 117–127 (1992).
3. J. Koning, P. Palmer, C. R. Franks, D. E. Mulder, J. L. Speyer, M. D. Green and K. Hellmann,Cardioxane-ICRF-187, towards anticancer drug specificity through selective toxicity reduction. Cancer Treat. Rev.18, 1–19 (1991).
4. E. H. Herman, V. J. Ferrans, C. E. Myers and J. F. Van Vleet,Comparison of the effectiveness of (±)-1,2-Bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) and n-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles. Cancer Res.45, 276–281 (1985).
5. E. H. Herman and V. J. Ferrans,Pretreatment with ICRF-187 provides long lasting protection against chronic daunorubicin cardiotoxicity in rabbits. Cancer Chemother. Pharmacol.16, 102–106 (1986).
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献